GSK-3α/β kinases and amyloid production in vivo
Authors:
- Tomasz JaworskiTJTomasz Jaworski
- Ilse DewachterIDIlse Dewachter
- Benoit LechatBLBenoit Lechat
- Maarten GeesMGMaarten Gees
- Anna KremerAKAnna Kremer
- David DemedtsDDDavid Demedts
- Peter BorghgraefPBPeter Borghgraef
- Herman DevijverHDHerman Devijver
- Seb KüglerSKSeb Kügler
- Satish PatelSPSatish Patel
- Jim R. WoodgettJWJim R. Woodgett
- Fred Van LeuvenFLFred Van Leuven
- 7 December 2011
- journal article
- editorial
- Published by Springer Nature in Nature
- Vol. 480 (7376) , E4-E5
Abstract
Arising from C. J. Phiel, C. A. Wilson, V. M.-Y. Lee & P. S. Klein Nature 423, 435-439 (2003) A major unresolved issue in Alzheimer/'s disease is identifying the mechanisms that regulate proteolytic processing of amyloid precursor protein (APP)[mdash]glycogen synthase kinase-3 (GSK-3) isozymes are thought to be important in this regulation. Phiel et al. proposed that GSK-3[agr], but not GSK-3[bgr], controls production of amyloid. We analysed the proteolytic processing of mouse and human APP in mouse brain in vivo in five different genetic and viral models. Our data do not yield evidence for either GSK-3[agr]-mediated or GSK-3[bgr]-mediated control of APP processing in brain in vivo.Keywords
This publication has 13 references indexed in Scilit:
- Pathological Hallmarks, Clinical Parallels, and Value for Drug Testing in Alzheimer's Disease of the APP[V717I] London Transgenic Mouse ModelInternational Journal of Alzheimer's Disease, 2010
- Abnormalities in brain structure and behavior in GSK-3alpha mutant miceMolecular Brain, 2009
- AAV-Tau Mediates Pyramidal Neurodegeneration by Cell-Cycle Re-Entry without Neurofibrillary Tangle Formation in Wild-Type MicePLOS ONE, 2009
- Amyloid Activates GSK-3β to Aggravate Neuronal Tauopathy in Bigenic MiceThe American Journal of Pathology, 2008
- GSK-3 is essential in the pathogenesis of Alzheimer's diseaseJournal of Alzheimer’s Disease, 2006
- GSK-3α regulates production of Alzheimer's disease amyloid-β peptidesNature, 2003
- Neuronal Deficiency of Presenilin 1 Inhibits Amyloid Plaque Formation and Corrects Hippocampal Long-Term Potentiation But Not a Cognitive Defect of Amyloid Precursor Protein [V717I] Transgenic MiceJournal of Neuroscience, 2002
- Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in BrainJournal of Biological Chemistry, 1999
- Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor proteinNature, 1998
- Glycogen synthase kinase 3β is identical to tau protein kinase I generating several epitopes of paired helical filamentsFEBS Letters, 1993